ARCA biopharma Inc (ABIO)

5.18 +0.11  +2.17% NASDAQ Sep 18, 20:00 USD

ARCA biopharma Cash from Investing (Quarterly):

-0.003M for June 30, 2020
View 4,000+ financial data types
Browse...
View Full Chart

Cash from Investing (Quarterly) Chart

Export Data
Save Image
Print Image

Historical Cash from Investing (Quarterly) Data

View and export this data going back to 1997. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
June 30, 2020 -0.003M
March 31, 2020 -0.003M
Dec. 31, 2019 -0.002M
Sept. 30, 2019 -0.002M
June 30, 2019 0.00
March 31, 2019 0.00
Dec. 31, 2018 0.00
Sept. 30, 2018 -0.003M
June 30, 2018 0.00
March 31, 2018 3.049M
Dec. 31, 2017 4.749M
Sept. 30, 2017 -0.932M
June 30, 2017 6.101M
March 31, 2017 3.008M
Dec. 31, 2016 3.148M
Sept. 30, 2016 -2.548M
June 30, 2016 -11.81M
March 31, 2016 -5.202M
Dec. 31, 2015 -0.002M
Sept. 30, 2015 -0.002M
June 30, 2015 -0.005M
March 31, 2015 -0.002M
Dec. 31, 2014 -0.014M
Sept. 30, 2014 0.00
June 30, 2014 -0.005M
   
March 31, 2014 0.00
Dec. 31, 2013 -0.004M
Sept. 30, 2013 -0.011M
June 30, 2013 -0.008M
March 31, 2013 -0.009M
Dec. 31, 2012 0.001M
Sept. 30, 2012 0.00
June 30, 2012 -0.001M
March 31, 2012 0.00
Dec. 31, 2011 0.005M
Sept. 30, 2011 0.001M
June 30, 2011 2.00M
March 31, 2011 0.00
Dec. 31, 2010 0.261M
Sept. 30, 2010 0.00
June 30, 2010 0.006M
March 31, 2010 -0.002M
Dec. 31, 2009 0.012M
Sept. 30, 2009 5.094M
June 30, 2009 4.39M
March 31, 2009 36.14M
Dec. 31, 2008 -43.71M
Sept. 30, 2008 42.23M
June 30, 2008 -23.26M
March 31, 2008 22.22M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

Advertisement

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (Quarterly) Benchmarks

Navidea Biopharmaceuticals Inc -0.0592M
VolitionRX Ltd -0.2667M
Celldex Therapeutics Inc -108.53M

Cash from Investing (Quarterly) Range, Past 5 Years

Minimum -11.81M Jun 2016
Maximum 6.101M Jun 2017
Average -0.0228M
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.